Debra Stephanie Barker
Director/Board Member chez BERGENBIO ASA
Fortune : 32 483 $ au 31/03/2024
Provenance du réseau au premier degré de Debra Stephanie Barker
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 | |
20
| Public Company | Pharmaceuticals: Major | 20 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.
16
| Subsidiary | Biotechnology | 16 |
| Public Company | Pharmaceuticals: Major | 15 | |
| Public Company | Investment Managers | 10 | |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York.
9
| Subsidiary | Investment Managers | 9 |
| Public Company | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Debra Stephanie Barker via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Compliance Officer | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IPSEN | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Public Communications Contact | |
| TIGENIX NV | Medical Specialties | Chairman Chairman | |
| GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member Director/Board Member | |
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Public Communications Contact | |
| University of Oxford | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| Oxford Brookes University | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
GlaxoSmithKline Biologicals NV
 GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Chairman Corporate Officer/Principal | |
| University of Leeds | College/University | Doctorate Degree Undergraduate Degree | |
| BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member Director/Board Member | |
| The University of Edinburgh | College/University | Graduate Degree Undergraduate Degree | |
| University of Bristol | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Durham | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Nottingham | College/University | Undergraduate Degree Undergraduate Degree | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree Doctorate Degree | |
| University of Oslo | College/University | Graduate Degree Graduate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree Doctorate Degree | |
| University of Bergen | College/University | Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
PricewaterhouseCoopers LLP (United Kingdom)
 PricewaterhouseCoopers LLP (United Kingdom) Other Consumer ServicesConsumer Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Sofia | College/University | Undergraduate Degree Graduate Degree | |
| London Business School | College/University | Masters Business Admin Masters Business Admin | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CHINA MEDICAL SYSTEM HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| ACACIA RESEARCH CORPORATION | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
Investinor AS
 Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Investment Managers | Chairman Private Equity Investor | |
Helse Bergen HF Haukeland Universitetssjukehus
 Helse Bergen HF Haukeland Universitetssjukehus Medical/Nursing ServicesHealth Services Helse Bergen HF Haukeland Universitetssjukehus is a healthcare company based in Bergen, Norway. Haukeland universitetssjukehus has over 14,000 skilled employees who work every day to provide patients with high-quality specialist health services when they need them. The Norwegian company is ultimately controlled by the Government of Norway. The private company was founded in 2001, and the CEO is Eivind Hansen. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
BePharBel Manufacturing SA
 BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
OncoDNA SA
 OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chairman Director/Board Member | |
| COSMO PHARMACEUTICALS N.V. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| Bergen Hospital Trust | Director/Board Member Chief Executive Officer | ||
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman Director/Board Member | |
Bristol-Myers Squibb GmbH & Co. KGaA
 Bristol-Myers Squibb GmbH & Co. KGaA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The private company is based in Munich, Germany. The CEO of the company is Han Steutel. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Allemagne | 12 |
| Royaume-Uni | 11 |
| Belgique | 10 |
| Norvège | 9 |
| Etats-Unis | 4 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 15 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 325 |
| Corporate Officer/Principal | 159 |
| Chairman | 120 |
| Independent Dir/Board Member | 69 |
| Chief Executive Officer | 62 |
Relations les plus connectées
| Insiders | |
|---|---|
| Baron Jean Stéphenne | 36 |
| Friedrich von Bohlen und Halbach | 36 |
| Anthony Rudd | 32 |
| François Thomas | 25 |
| Martin Olin | 25 |
| Sveinung Hole | 25 |
| Maureen O'Connell | 24 |
| Hans Tanner | 24 |
| Craig Tooman | 22 |
| Hilde Furberg | 21 |
| Isaac Kohlberg | 20 |
| Mathias Hothum | 19 |
| Huai Zheng Peng | 19 |
| Nick Rodgers | 18 |
| Peregrine Moncreiffe | 18 |
- Bourse
- Insiders
- Debra Stephanie Barker
- Connexions Sociétés
